Recap: Collegium Pharmaceutical Q1 Earnings - Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical COLL reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Collegium Pharmaceutical beat estimated earnings by 325.81%, reporting an EPS of $1.32 versus an estimate of $0.31.

Revenue was up $61.02 million from the same period last year.

Last quarter the company beat on EPS by $1.23 which was followed by a 0.94% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.14	-0.13	1.45	0.90
EPS Actual	1.09	1.10	0.33	0.42
Revenue Estimate	125.19M	124.45M	121.80M	78.88M
Revenue Actual	129.62M	127.01M	123.55M	83.75M

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.